GAPP 2 Survey: Global Attitudes of Patients and Physicians in Insulin Therapy for Type 2 Diabetes Mellitus
| Status: | Completed |
|---|---|
| Conditions: | Diabetes, Diabetes |
| Therapuetic Areas: | Endocrinology |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 1/14/2017 |
| Start Date: | January 2012 |
| End Date: | January 2013 |
This study is conducted Asia, Europe and North America. The aim of this study is to describe
insulin therapy adherence and the burden of non-adherence on patient functioning, well-being
and diabetes management.
insulin therapy adherence and the burden of non-adherence on patient functioning, well-being
and diabetes management.
Inclusion Criteria:
- PATIENTS WITH T2DM:
- Diagnosed with type 2 diabetes by a healthcare professional
- Currently being treated with insulin medication, excluding premix insulin treatment
- Age at least 40 years
- Diagnosed as having type 2 diabetes over the age of 40
- HCPs:
- Primary care physician, diabetes specialist (diabetologist/endocrinologist) or
diabetes specialist nurse/diabetes nurse educator
- Have a minimum of 2 years experience within current speciality
- See a minimum of 20 type 2 diabetes patients per month (40 for diabetes specialists),
of which at least 10 per month must be on modern (analogue) inulins
We found this trial at
2
sites
Click here to add this to my saved trials
Click here to add this to my saved trials